CANDEL THERAPEUTICS, INC. (CADL) Return on equity 2022–2023
CANDEL THERAPEUTICS, INC. (CADL) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-79.5%FY2023 · since FY2022: -29.3% → -79.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -79.5% | -50.2 pp |
| FY2022 | -29.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice